Essential
phospholipids are the main elements of the structure of the cell membrane and cellular organelles. In diseases of the liver, there is always damage to the membranes of the liver cells and their organelles, which leads to disturbances in the activity of the enzymes and receptor systems associated with them, impairment of the functional activity of the hepatic cells, and a decrease in the ability to regenerate.
Phospholipids, which are part of the preparation, correspond in their chemical structure to endogenous phospholipids, but exceed the endogenous
phospholipids by activity due to the higher content of polyunsaturated (essential) fatty acids in them.The incorporation of these high-energy molecules into the damaged parts of the cell membranes of hepatocytes restores the integrity of the hepatic cells, promotes their regeneration. Since cis-double bonds of their polyunsaturated fatty acids prevent the parallel arrangement of hydrocarbon chains of phospholipid membranes, the density of phospholipid structures is weakened, which increases the metabolic rate. The resulting functional blocks increase the activity of enzymes fixed on the membranes and promote the normal, physiological pathway of the most important metabolic processes.
Phospholipids, included in the drug, interfere with impaired lipid metabolism by regulating the metabolism of lipoproteins in such a way that neutral fats and cholesterol pass into transportable forms, mainly by increasing the cholesterol-binding capacity of high-density lipoproteins, and thus may be susceptible to oxidation . Thus, there is a normalizing effect on the metabolism of lipids andproteins; on the detoxification function of the liver; on the restoration and preservation of the cellular structure of the liver and phospholipid-dependent enzyme systems, which ultimately prevents the formation of connective tissue in the liver.